Antibiotics and other antimicrobials are often administered to terminally ill patients. But given widespread concern about antibiotic resistance, this common practice should be reconsidered by providers, patients, and families, according to a Yale...
Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.The finding, published Aug. 27 in PLOS ONE,...